Abstract 68: Laparoscopic Sleeve Gastrectomy as a treatment option for Type 2 Diabetes Mellitus

Background: Metabolic diseases have been associated with morbid obesity, hypertension and diabetes mellitus being the most common. Laparoscopic sleeve gastrectomy has been used as a primary procedure for weight control with acceptable records of effective weight loss together with evidence of improvement of associated comorbidities. Methods: The patients enrolled for bariatric surgery were thoroughly screened for diabetes mellitus and if already diabetic, their diabetic control (HbA1c, fasting blood sugars) and treatment protocols were recorded. Post-surgery patients were followed (minimum 6 months). Our primary outcome target was studying the effect of surgery on weight loss and diabetic control. Remission of type 2 DM was considered when postoperative levels of HbA1c score less than 6.5% and fasting blood glucose less than 126 mg/dl with no oral medications or insulin. Results: Fifteen patients were diagnosed with morbid obesity with DM. Laparoscopic sleeve gastrectomy was done to treat obesity and comorbid conditions. Among them, fourteen patients had significant improvement of their glycaemic control and five managed to stop the hypoglycaemic medication. Conclusion: LSG plays a significant role as a metabolic control procedure rather than a bariatric restrictive procedure only.